CSIMarket
 


Omniab Inc   (OABI)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

OABI's Revenue Growth by Quarter and Year

Omniab Inc 's Revenue results by quarter and year




OABI Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 4.82 59.08 0.00
III Quarter September - 5.48 0.00 0.00
II Quarter June - 6.95 0.00 0.00
I Quarter March 3.80 16.92 0.00 0.00
FY   3.80 34.17 59.08 0.00



OABI Revenue first quarter 2024 Y/Y Growth Comment
Omniab Inc reported drop in Revenue in the first quarter 2024 by -77.54% to $ 3.80 millions, from the same quarter in 2023.
The fall in the first quarter 2024 Omniab Inc 's Revenue compares unfavorably to the Company's average Revenue no change of 0%.

Looking into first quarter 2024 results within Medical Laboratories industry 25 other companies have achieved higher Revenue growth. While Omniab Inc ' s Revenue meltdown of -77.54% ranks overall at the positon no. 2542 in the first quarter 2024.




OABI Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - -91.84 % - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March -77.54 % - - -
FY   - -42.16 % - -

Financial Statements
Omniab Inc 's first quarter 2024 Revenue $ 3.80 millions OABI's Income Statement
Omniab Inc 's first quarter 2023 Revenue $ 16.92 millions Quarterly OABI's Income Statement
New: More OABI's historic Revenue Growth >>


OABI Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - -12.04 % - -
III Quarter September - -21.15 % - -
II Quarter June - -58.92 % - -
I Quarter March -21.14 % -71.36 % - -
FY (Year on Year)   - -42.16 % - -




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #26
Healthcare Sector #345
Overall #2542

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #26
Healthcare Sector #345
Overall #2542
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Omniab Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
-11.96 % -36.92 % -71.36 %
(Dec 31 2023)  


OABI's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Omniab Inc disclosed fall in Revenue from the fourth quarter by -21.14% to $ 3.80 millions, from $ 4.82 millions achived a quarter before.

It's not big issue, as I. Quarter Revenue frequently gravitate to slow in the I. Quarter.

Within Medical Laboratories industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Omniab Inc 's Revenue growth quarter on quarter, overall rank is 2163.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #24
Healthcare Sector #282
Overall #2163
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #24
Healthcare Sector #282
Overall #2163
Revenue Q/Q Growth Statistics
High Average Low
-11.96 % -36.92 % -71.36 %
(Dec 31 2023)  


OABI's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Omniab Inc realized fall in Revenue sequentially by -21.14% to $ 3.80 millions, from $ 4.82 millions declared a quarter before.

This is not important issue, as Omniab Inc 's Revenue frequently seem to dip in the I. Quarter.

Within Medical Laboratories industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Omniab Inc 's Revenue growth quarter on quarter, overall rank is 2163.


Omniab Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 21.05 $ 34.16 $ 88.42 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -38.4 % -61.36 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 2751 # 2974 # 0 # 0 # 0




Cumulative Revenue growth Comment


Omniab Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 26
Sector # 369
S&P 500 # 2751
Cumulative Revenue growth Comment


Omniab Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 26
Sector # 369
S&P 500 # 2751




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OABI's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for OABI's Competitors
Revenue Growth for Omniab Inc 's Suppliers
Revenue Growth for OABI's Customers

You may also want to know
OABI's Annual Growth Rates OABI's Profitability Ratios OABI's Asset Turnover Ratio OABI's Dividend Growth
OABI's Roe OABI's Valuation Ratios OABI's Financial Strength Ratios OABI's Dividend Payout Ratio
OABI's Roa OABI's Inventory Turnover Ratio OABI's Growth Rates OABI's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Collegium Pharmaceutical inc -0.21%$ -0.215 millions
Mettler Toledo International Inc-0.30%$ -0.300 millions
3m Company-0.35%$ -0.349 millions
Icu Medical Inc-0.42%$ -0.423 millions
Lifeloc Technologies Inc -0.51%$ -0.513 millions
Regeneron Pharmaceuticals Inc -0.54%$ -0.541 millions
Envista Holdings Corporation-0.62%$ -0.622 millions
Orgenesis Inc -0.70%$ -0.704 millions
Vyne Therapeutics Inc -1.01%$ -1.010 millions
Ge Healthcare Technologies Inc -1.50%$ -1.502 millions
Baxter International Inc -1.56%$ -1.562 millions
Y mabs Therapeutics inc -1.58%$ -1.580 millions
Pacific Biosciences Of California Inc -1.59%$ -1.589 millions
Cartesian Therapeutics Inc -1.65%$ -1.650 millions
Viatris Inc -1.76%$ -1.762 millions
Ocuphire Pharma Inc -2.17%$ -2.173 millions
Vaso Corporation-2.51%$ -2.513 millions
Dentsply Sirona Inc -2.56%$ -2.556 millions
Alpha Pro Tech Ltd -2.78%$ -2.775 millions
Prestige Consumer Healthcare Inc -2.82%$ -2.817 millions
West Pharmaceutical Services Inc -2.99%$ -2.986 millions
Integra Lifesciences Holdings Corp-3.14%$ -3.144 millions
Accelerate Diagnostics Inc -3.17%$ -3.165 millions
National Research Corporation-3.18%$ -3.180 millions
Catheter Precision Inc -3.53%$ -3.529 millions
Elanco Animal Health Inc-4.14%$ -4.137 millions
Ptc Therapeutics inc -4.66%$ -4.657 millions
Foghorn Therapeutics Inc -4.88%$ -4.879 millions
Aclaris Therapeutics Inc -5.14%$ -5.142 millions
Avantor Inc -5.65%$ -5.645 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com